ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 757–768 of 2020 project topics
Benzodiazepine Metabolism Genetic Risk Assessment Tool
A mobile and web application that identifies CYP3A4 and CYP2C19 polymorphisms associated with benzodiazepine accumulation and overdose risk in psychiatric patients. The platform monetizes through provider licensing fees, pharmacy integration partnerships, and data analytics services for pharmaceutical companies conducting post-market surveillance.
Pharmacogenomics of Psychiatric Medications Click to view more details →
Monoamine Oxidase Inhibitor Genetic Compatibility Screening
A specialized genetic testing panel that screens for variants affecting MAOI metabolism and drug-drug interaction risks before prescribing these medications. This service creates revenue through direct-to-patient marketing, clinician referral networks, and premium consultation services for complex psychiatric medication management.
Pharmacogenomics of Psychiatric Medications Click to view more details →
Stimulant Response Genotyping for ADHD Pharmacotherapy
An integrated diagnostic platform analyzing SLC6A3 and CYP2D6 variants to predict methylphenidate and amphetamine response and tolerability in ADHD patients. This platform generates revenue through B2B licensing to psychiatric clinics, school-based health programs, and direct-to-consumer telehealth partnerships.
Pharmacogenomics of Psychiatric Medications Click to view more details →
Antipsychotic Weight Gain and Metabolic Risk Genetics
A predictive analytics software that integrates HTR2C and LEP gene variants with clinical data to forecast metabolic side effects and weight gain liability from atypical antipsychotics. This platform monetizes through hospital system contracts, mental health clinic subscriptions, and pharmaceutical company sponsorships for real-world evidence studies.
Pharmacogenomics of Psychiatric Medications Click to view more details →
Craniosynostosis Gene Panel Testing
Developing panels covering FGFR1, FGFR2, FGFR3, TWIST1, and EFNB1 for molecular diagnosis of syndromic and non-syndromic craniosynostosis.
Genetic Basis of Craniofacial Disorders Click to view more details →
Cleft Lip and Palate Genetic Risk Factors
Identifying common genetic risk variants and rare mutations contributing to non-syndromic cleft lip and palate through GWAS and family sequencing studies.
Genetic Basis of Craniofacial Disorders Click to view more details →
Treacher Collins TCOF1 Variant Analysis
Characterizing TCOF1 pathogenic variants and correlating with Treacher Collins syndrome severity for molecular diagnosis and genetic counseling.
Genetic Basis of Craniofacial Disorders Click to view more details →
Van der Woude Syndrome IRF6 Testing
Developing IRF6 and GRHL3 molecular testing for Van der Woude syndrome diagnosis and distinguishing from non-syndromic cleft lip and palate.
Genetic Basis of Craniofacial Disorders Click to view more details →
Pierre Robin Sequence Diagnostic SaaS Platform
A cloud-based diagnostic platform integrating genetic sequencing data with clinical phenotyping tools to identify SOX9 and other pathogenic variants associated with Pierre Robin sequence. This enables clinicians to deliver precision diagnoses while generating recurring subscription revenue and high-throughput sample processing fees.
Genetic Basis of Craniofacial Disorders Click to view more details →
Hemifacial Microsomia Gene Variant Commercial Database
A proprietary genomic database cataloging OFD1, DHCR7, and emerging variants linked to hemifacial microsomia with predictive phenotype modeling software. Licensing this database to genetic testing labs and clinical providers creates B2B SaaS revenue while supporting patient risk stratification and surgical planning.
Genetic Basis of Craniofacial Disorders Click to view more details →
Ectodermal Dysplasia Mutation Screening Enterprise Software Tool
An enterprise-grade bioinformatics tool automating detection of EDA, EDAR, and EDARADD mutations across multi-gene panels for high-volume diagnostic labs. This accelerates time-to-result while reducing manual review costs, enabling labs to increase throughput capacity and generate margin expansion on testing services.
Genetic Basis of Craniofacial Disorders Click to view more details →
Amelogenesis Imperfecta Genetic Risk Prediction API
A machine learning-powered REST API predicting amelogenesis imperfecta severity based on AMELX, ENAM, and KLK4 variant profiles integrated into dental and orthodontic software platforms. Monetization occurs through per-prediction API calls and white-label licensing to dental software vendors and insurance companies for treatment planning.
Genetic Basis of Craniofacial Disorders Click to view more details →